(Reuters) - PHILADELPHIA, April 16 - Medical-testing company Quest Diagnostics Inc. said on Monday it will acquire diagnostic testing equipment company AmeriPath Inc. for $1.23 billion in cash, boosting Quest's cancer-detection business.
AmeriPath, controlled by Welsh, Carson, Anderson and Stowe IX L.P., provides dermatopathology, anatomic pathology and esoteric testing and has annual revenue of more than $800 million.
Read more at Reuters.com Mergers News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment